Fractyl Health, Inc. Proceeds from Notes Payable
Fractyl Health, Inc. (GUTS) reported Proceeds from Notes Payable of $28.43 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2025-03-03
- Fractyl Health, Inc. proceeds from notes payable for the quarter ending 2023-12-31 was $0.00.
- Fractyl Health, Inc. proceeds from notes payable for fiscal 2023 was $28.43M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $28.43M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $28.43M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |